OIA Response: Zytiga data

Request dated 13 December 2018 for information relating to Zytiga.

29 January 2019

[Name and contact details redacted]

Dear [Name redacted]

REQUEST FOR INFORMATION

Thank you for your request dated 13 December 2018 under the Official Information Act 1982 (OIA) for information relating to Zytiga.  You asked for the latest available data on Special Authority (SA) numbers for Zytiga (abiraterone) use in prostate cancer.

The information requested is set out in the table below. The data range refers to a financial year, which runs from 1 July to 30 June. Note that patients can have more than one renewal.

Financial Year

Month Submitted

Initial SA

SA Renewal

2014/15

April

5

0

 

May

165

1

 

June

75

2

2015/16

July

52

5

 

August

57

10

 

September

41

10

 

October

31

31

 

November

29

58

 

December

32

51

 

January

36

35

 

February

23

34

 

March

30

27

 

April

32

36

 

May

38

64

 

June

28

37

2016/17

July

40

30

 

August

35

54

 

September

32

39

 

October

26

36

 

November

37

51

 

December

26

44

 

January

39

51

 

February

30

47

 

March

33

41

 

April

35

45

 

May

51

53

 

June

41

51

2017/18

July

32

51

 

August

38

60

 

September

41

46

 

October

34

38

 

November

46

65

 

December

38

61

 

January

33

37

 

February

27

66

 

March

44

62

 

April

24

62

 

May

49

78

 

June

37

45

2018/19

July

35

52

 

August

50

53

 

September

42

57

 

October

30

66

Total

 

1699

1842

We trust that the provision of this information answers your queries, if you have any further questions please feel free to contact us again.

Yours sincerely

[Alison Hill's signature]

Alison Hill
Director, Engagement and Implementation